Esketamiini (Finnish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Esketamiini" in Finnish language version.

refsWebsite

Global rank Finnish rank

low place

165^th place

1pharmacafennica.fi

low place

904^th place

447^th place

676^th place

92^nd place

388^th place

4^th place

12^th place

2^nd place

10^th place

5^th place

9^th place

1,226^th place

929^th place

bmj.com (Global: 1,226^th place; Finnish: 929^th place)

Elisabeth Mahase: Esketamine is approved in Europe for treating resistant major depressive disorder. BMJ, 20.12.2019, nro 367. PubMed:31862692 doi:10.1136/bmj.l7069 ISSN 1756-1833 Artikkelin verkkoversio. (englanniksi)

doi.org (Global: 2^nd place; Finnish: 10^th place)

dx.doi.org

Elisabeth Mahase: Esketamine is approved in Europe for treating resistant major depressive disorder. BMJ, 20.12.2019, nro 367. PubMed:31862692 doi:10.1136/bmj.l7069 ISSN 1756-1833 Artikkelin verkkoversio. (englanniksi)

fda.gov (Global: 447^th place; Finnish: 676^th place)

Office of the Commissioner: FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor’s office or clinic FDA. 24.3.2020. Viitattu 29.8.2020. (englanniksi)

fimea.fi (Global: low place; Finnish: 165^th place)

spc.fimea.fi

fimea.fi

Lääkehaku: Spravato Fimea. Viitattu 29.8.2020.

nih.gov (Global: 4^th place; Finnish: 12^th place)

pubmed.ncbi.nlm.nih.gov

Elisabeth Mahase: Esketamine is approved in Europe for treating resistant major depressive disorder. BMJ, 20.12.2019, nro 367. PubMed:31862692 doi:10.1136/bmj.l7069 ISSN 1756-1833 Artikkelin verkkoversio. (englanniksi)

npr.org (Global: 92^nd place; Finnish: 388^th place)

FDA Approves A Nasal Spray To Treat Patients Who Are Suicidal NPR.org. Viitattu 29.8.2020. (englanniksi)

pharmacafennica.fi (Global: low place; Finnish: 904^th place)

KETANEST-S injektio-/infuusioneste, liuos 5 mg/ml, 25 mg/ml - Pharmaca Fennica pharmacafennica.fi. Viitattu 29.8.2020.

worldcat.org (Global: 5^th place; Finnish: 9^th place)

Elisabeth Mahase: Esketamine is approved in Europe for treating resistant major depressive disorder. BMJ, 20.12.2019, nro 367. PubMed:31862692 doi:10.1136/bmj.l7069 ISSN 1756-1833 Artikkelin verkkoversio. (englanniksi)